ARCHIVES

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Centers’ Problems Get Increasing Attention From Staff, Advisors

August 20, 1976

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program.

November 12, 2004

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014